TrialCirculation2023

Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial.

Gregory Piazza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.